SELLAS Life Sciences Group Inc.(SLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLS SELLAS Life Sciences Group Inc.

Pre-Mkt 10-29 08:41:42 EDT

10.38

-1.79

-14.71%

盘前10.26

-0.12-1.13%

08:41 EDT

High12.44	Low9.71	Vol23.77M
Open12.20	D1 Closing12.17	Amplitude22.47%
Mkt Cap2.10B	Tradable Cap2.07B	Total Shares201.95M
T/O247.89M	T/O Rate11.95%	Tradable Shares199.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SLS","market":"US","secType":"STK","nameCN":"SELLAS Life Sciences Group Inc.","latestPrice":10.38,"timestamp":1793217600000,"preClose":12.17,"halted":0,"volume":23771723,"hourTrading":{"tag":"盘前","latestPrice":10.2631,"preClose":10.38,"latestTime":"08:41 EDT","volume":89098,"amount":919244.3803440001,"timestamp":1793277698028,"change":-0.1169,"changeRate":-0.011262,"amplitude":0.026012},"delay":0,"changeRate":-0.14708299096138036,"floatShares":199000000,"shares":201945709,"eps":-0.212307,"marketStatus":"Pre-Mkt","change":-1.79,"latestTime":"10-29 08:41:42 EDT","open":12.2,"high":12.44,"low":9.705,"amount":247893191.46461,"amplitude":0.224733,"askPrice":10.28,"askSize":200,"bidPrice":10.22,"bidSize":480,"shortable":0,"etf":0,"ttmEps":-0.212307,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793280600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":10.38,"preHourTrading":{"tag":"盘前","latestPrice":10.2631,"preClose":10.38,"latestTime":"08:41 EDT","volume":89098,"amount":919244.3803440001,"timestamp":1793277698028,"change":-0.1169,"changeRate":-0.011262,"amplitude":0.026012},"postHourTrading":{"tag":"盘后","latestPrice":10.36,"preClose":10.38,"latestTime":"19:59 EDT","volume":305076,"amount":3168348.374,"timestamp":1793231999279,"change":-0.02,"changeRate":-0.001927,"amplitude":0.012524},"volumeRatio":4.776860235085333,"optionData":{"bulkOrders":[{"symbol":"SLS","call":false,"expireDate":1799989200000,"strike":"6.0","timestamp":1793195445006,"price":2.3,"volume":10000,"amount":2300000,"type":"+"},{"symbol":"SLS","call":false,"expireDate":1799989200000,"strike":"6.0","timestamp":1793198675196,"price":2.5,"volume":7416,"amount":1854000,"type":"+"}]},"impliedVol":2.5382,"impliedVolPercentile":0.908},"requestUrl":"/m/hq/s/SLS","defaultTab":"news","newsList":[{"id":"2679492087","title":"Sellas Life Sciences falls -17.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679492087","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679492087?lang=en_us&edition=fundamental","pubTime":"2026-10-29 00:06","pubTimestamp":1793203565,"startTime":"0","endTime":"0","summary":"Sellas Life Sciences (SLS) is down -17.7%, or -$2.15 to $10.02. Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-falls-17-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-falls-17-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678492881","title":"SELLAS Life Sciences Stock (SLS) Slides 18% as a Phase 3 Study Enters Its Evaluation Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2678492881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678492881?lang=en_us&edition=fundamental","pubTime":"2026-10-28 23:19","pubTimestamp":1793200773,"startTime":"0","endTime":"0","summary":"SELLAS Life Sciences stock dropped over 18% on Wednesday alongside a clinical trial update.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/sellas-life-sciences-stock-sls-slides-18-as-a-phase-3-study-enters-its-evaluation-period?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/sellas-life-sciences-stock-sls-slides-18-as-a-phase-3-study-enters-its-evaluation-period?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678460204","title":"Sellas' Phase 3 AML Trial Reaches 80th Death, Triggering Final Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2678460204","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678460204?lang=en_us&edition=fundamental","pubTime":"2026-10-28 20:35","pubTimestamp":1793190937,"startTime":"0","endTime":"0","summary":"Sellas' Phase 3 AML Trial Reaches 80th Death, Triggering Final AnalysisSellas Life Sciences' Phase 3 REGAL trial of galinpepimut-S in acute myeloid leukemia reached its prespecified 80th death, trigge","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDLFnvTy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BQXX3C00.GBP","BK4112","SG9999014005.SGD","BCDF","LU2210149790.SGD","BK4588","SG9999014039.USD","BK4585","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU0314104364.USD","IE00BQXX3F31.USD","NDAQ","IE00BKPKM429.USD","SLS","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4139","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678260460","title":"Sellas Life Sciences Reaches 80TH Event in Phase 3 Regal Trial of Galinpepimut-S (Gps) in Acute Myeloid Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2678260460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678260460?lang=en_us&edition=fundamental","pubTime":"2026-10-28 20:35","pubTimestamp":1793190900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nTUA8J6H0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678063460","title":"Sellas Life Sciences Group - to Report Topline Primary Endpoint Results from Regal Trial This Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2678063460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678063460?lang=en_us&edition=fundamental","pubTime":"2026-10-28 20:35","pubTimestamp":1793190900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nTUA8J6H0K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678151109","title":"SLS Bio to be Delisted from KOSDAQ on Nov. 5 Following KRX Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2678151109","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678151109?lang=en_us&edition=fundamental","pubTime":"2026-10-26 14:16","pubTimestamp":1792995400,"startTime":"0","endTime":"0","summary":"SLS Bio (KOSDAQ:246250) will be delisted from South Korea's KOSDAQ market on Nov. 5, according to a Monday filing with the Korea Exchange.The Korea Exchange finalized the delisting decision following ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SLS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2675745590","title":"Sellas Life Sciences falls -12.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675745590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675745590?lang=en_us&edition=fundamental","pubTime":"2026-10-16 22:05","pubTimestamp":1792159546,"startTime":"0","endTime":"0","summary":"Sellas Life Sciences (SLS) is down -12.5%, or -$1.42 to $9.92. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-falls-12-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-falls-12-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673401933","title":"Sellas Life Sciences put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2673401933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673401933?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:55","pubTimestamp":1791384916,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Sellas Life Sciences (SLS) with 9,677 puts trading, or 3x expected. Most active are Jan-27 10 puts and Oct-26 15 calls, with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222363","title":"Solstice Minerals Limited (SLS) Receives a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222363","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222363?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:35","pubTimestamp":1790724925,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Paul Howard CFA from Canaccord Genuity maintained a Buy rating on Solstice Minerals Limited, with a price target of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/solstice-minerals-limited-sls-receives-a-buy-from-canaccord-genuity-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/solstice-minerals-limited-sls-receives-a-buy-from-canaccord-genuity-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS","BK4139","CFA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670429587","title":"Sellas Life Sciences presents preclinical data on SLS009 at AACR Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2670429587","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670429587?lang=en_us&edition=fundamental","pubTime":"2026-09-26 01:05","pubTimestamp":1790355920,"startTime":"0","endTime":"0","summary":"SELLAS Life Sciences (SLS) Group announced preclinical data from studies evaluating SLS009, its highly selective cyclin-dependent kinases 9 inhibit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-presents-preclinical-data-on-sls009-at-aacr-conference-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-presents-preclinical-data-on-sls009-at-aacr-conference-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670260364","title":"Sellas Presents Preclinical Data on Sls009 CDK9 Inhibitor in Pancreatic Cancer Organoid Models at AACR Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2670260364","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670260364?lang=en_us&edition=fundamental","pubTime":"2026-09-26 01:00","pubTimestamp":1790355625,"startTime":"0","endTime":"0","summary":"Sellas presents preclinical data on SLS009 CDK9 inhibitor in pancreatic cancer organoid models at AACR conferenceSellas Life Sciences disclosed preclinical pancreatic cancer data for SLS009, a CDK9 in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nNDL1jCXJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","SLS","NDAQ","IE00BN0W2T93.GBP","SG9999014039.USD","LU0314104364.USD","BK4588","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","SG9999014021.USD","SG9999014005.SGD","BK4139","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","LU2095319765.USD","IE00BQXX3F31.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663121","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663121","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663121?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:44","pubTimestamp":1789386292,"startTime":"0","endTime":"0","summary":"Waldencast  shares were down 41% pre-bell Monday after the company said it plans to voluntarily delist its Class A ordinary shares and warrants from Nasdaq.Landvision Technology  stock was 17% lower following a 52% rise in Friday's session.Sellas Life Sciences  shares were down 15%, extending the 14% loss from the prior close.Olema Pharmaceuticals  stock was 11% lower after a 4% fall in the previous session.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MKDW","BK4124","SLS.AU","BK4505","BK4139","BK7104","OLMA","WALD","SLS","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113865065","title":"Movement Alert｜SELLAS Life Sciences Group Inc. Falls 8.19% in Pre-Market Trading, Trading at $10.7","url":"https://stock-news.laohu8.com/highlight/detail?id=1113865065","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113865065?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:53","pubTimestamp":1789379635,"startTime":"0","endTime":"0","summary":"On September 14, SELLAS Life Sciences Group Inc. fell 8.19% in pre-market trading, trading at $10.70 USD/share, with turnover of $438,600. The stock had already declined 14.42% in the prior trading...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147638957","title":"Movement Alert｜SELLAS Life Sciences Group Inc. Falls 9.35% in Regular Trading, Trading at $12.28","url":"https://stock-news.laohu8.com/highlight/detail?id=1147638957","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147638957?lang=en_us&edition=fundamental","pubTime":"2026-09-12 01:47","pubTimestamp":1789148877,"startTime":"0","endTime":"0","summary":"On September 11, SELLAS Life Sciences Group Inc. fell 9.35% in regular trading, trading at $12.28 USD/share, with Turnover of $88.60 million.Within the Biotechnology sector where SELLAS Life Sciences...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665391548","title":"Bell Potter Reaffirms Their Buy Rating on Solstice Minerals Limited (SLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665391548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665391548?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:25","pubTimestamp":1788758711,"startTime":"0","endTime":"0","summary":"Bell Potter analyst Todd Lewis maintained a Buy rating on Solstice Minerals Limited yesterday and set a price target of A$3.25. Lewis covers the Ba...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bell-potter-reaffirms-their-buy-rating-on-solstice-minerals-limited-sls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bell-potter-reaffirms-their-buy-rating-on-solstice-minerals-limited-sls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664112218","title":"SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664112218","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664112218?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"- Three posters to highlight preclinical activity of SLS009 (tambiciclib) across patient-derived KRAS mutant organoid models of pancreatic cancer – - Studies conducted in collaboration with the Univer","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355136/0/en/sellas-life-sciences-to-present-preclinical-data-on-sls009-in-pancreatic-ductal-adenocarcinoma-at-the-2026-aacr-conference-on-pancreatic-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886743","title":"Canaccord Genuity Sticks to Their Buy Rating for Solstice Minerals Limited (SLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886743","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886743?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:35","pubTimestamp":1788219338,"startTime":"0","endTime":"0","summary":"In a report released today, Paul Howard CFA from Canaccord Genuity maintained a Buy rating on Solstice Minerals Limited, with a price target of A$2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-solstice-minerals-limited-sls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-solstice-minerals-limited-sls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663807404","title":"Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; SELLAS Life Sciences to Advance, Tesla to Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2663807404","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663807404?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:38","pubTimestamp":1788172689,"startTime":"0","endTime":"0","summary":"The most-talked-about stocks in the Reddit subforum Wallstreetbets were mixed hours before Monday's opening bell.SELLAS Life Sciences Group  rose 2% pre-bell, after a 13.2% decline from the previous session.Nvidia  was 0.5% higher premarket, swinging from a 4.6% fall at Friday's close.Broadcom  was up 0.2% hours before market open, following a 0.7% decline from Friday's session.Sandisk  advanced by 0.1% in pre-bell activity, after closing Friday with a slight increase.Tesla  fell by 0.5% pre-bell, following a 1.7% fall at Friday's close.Micron Technology  was down 0.4% in premarket hours, after a 0.3% decline from the previous session.Marvell Technology  was 0.4% lower premarket, following a 0.3% fall from Friday's session.Apple  was marginally declining pre-bell, swinging from a 1.6% increase at Friday's close.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0511384066.AUD","2NVD.UK","TSL","LU0274383776.USD","LU2355687059.USD","LU1400636574.HKD","LU2637965513.SGD","LU2764263203.CNY","LU0557290698.USD","LU0289960550.SGD","HK0000532082.HKD","MRVU","LU0823434583.USD","LU0029864427.USD","LU0345768153.USD","IE00BKPKM429.USD","LU2089985449.USD","LU2249611893.SGD","SNVDAmain","LU1880398471.USD","IE000M9KFDE8.USD","AAPB","LU0979878070.USD","LU1074936037.SGD","LU2322448957.HKD","IE00B3SWFQ91.USD","LU0868494617.USD","LU2298321311.HKD","SG9999001424.SGD","BK4549","MUD","IE00BQXX3F31.USD","LU2108987350.USD","LU1935042991.SGD","LU1267930813.SGD","LU2456880835.USD","AVGC","LU2168564065.EUR","TSLO","SG9999015341.SGD","BK4574","LU1670710661.SGD","LU1983260115.SGD","LU0080751232.USD","LU1720051108.HKD","AVGX","LU1037948897.HKD","LU2077746001.SGD","LU1291159041.SGD","LU2237443622.USD","LU0861579265.USD","IE00BGHQF631.EUR","NVD","SG9999014542.SGD","LU0316494557.USD","LU0289961442.SGD","LU1791710582.SGD","LU0310799852.SGD","LU0494093205.USD","LU1974910355.USD","TSLA","SNXX","LU0006306889.USD","IE00BJJMRX11.SGD","IE00B19Z3B42.SGD","LU0965509010.AUD","LU1670711123.USD","LU2286300806.USD","LU2210150020.SGD","LU0094547139.USD","NVDB","NVD2.UK","SHOC","TSLR","FSMD","NVDQ","LU0957808578.USD","LU1633808545.USD","LU2756315318.SGD","IE000F7OJYX1.SGD","LU0882574139.USD","LU0466842654.USD","ANV","SG9999014914.USD","LU1674673691.USD","LU2394011477.USD","LU1551013342.USD","LU2458330169.SGD","BK4550","IE00BMCWC346.EUR","LU0124676726.USD","SG9999014575.USD","LU1914381329.SGD","STSLAmain","LU0158827781.USD","TYLG","TESL","CMAG","CNAV","LU0823417653.USD","LU1992135472.HKD","FDRV","CLSE","LU0719512351.SGD","LU1119994496.HKD","NVIW.SI","LU2097344357.USD","LU2491050154.USD","BK4543","BK4559","IE0004086264.USD","LU2505996509.AUD","GAMR","SGXZ23171101.USD","TTXU","BK4527","LU0072461881.USD","07766","LU1066051498.USD","LU1917777945.USD","ELOL","LU2471134879.HKD","LU0289739343.SGD","IE00B5TLWC47.USD","LU0323240290.USD","LU2360106780.USD","LU0210533765.USD","IXN","LU0345770308.USD","ESLG","LU2028103732.USD","LU2462157665.USD","NVDS.UK","IE00BN8TJ469.HKD","LU1244550494.USD","LU2098885051.SGD","IE0002270589.USD","LU0157215616.USD","DIPS","IE0003U64NQ7.SGD","LU1035773651.USD","NVDL","LU2125909593.SGD","LU0081259029.USD","HK0000819398.USD","LEGR","LU0256863902.USD","LU2133065610.SGD","LU1066051225.USD","09366","DTCR","IE00BJTD4N35.SGD","IE00BYXW3230.USD","BK4533","LU2247934214.USD","TSDD","LU0957791311.USD","IE0004445015.USD","LU1815336760.USD","LU1366333091.USD","IE0034235295.USD","LU1778281490.HKD","BK4551","LU1868837300.USD","VGT","LU0127658192.USD","LU1366192091.USD","LU0320765059.SGD","IE00BHPRN162.USD","SG9999018865.SGD","LU2242649171.HKD","LU0784384876.USD","LU0823434740.USD","LU0208291251.USD","LU2360032135.SGD","BK4511","LU0048584097.USD","LU1582987597.SGD","LU2433249047.HKD","LU2265009873.SGD","LU1506573853.SGD","LU0738911758.USD","HK0000320264.USD","LU2999663052.SGD","LU0345768740.USD","LU2746668974.SGD","LU1861220033.SGD","FCUS","SNPE","IE00BQXX3D17.EUR","LU0143551892.USD","LU2506951875.HKD","IE00B3M56506.USD","SG9999001440.SGD","LU2750360997.AUD","IE00BYV24P56.USD","LU0943347566.SGD","IE00B19Z9P08.USD","LU1571399168.USD","LU0820562030.AUD","TSLT","LU2360107168.USD","LU3102509885.SGD","LU0689626769.HKD","LU2125909247.SGD","LU1301847155.USD","LU0726765562.USD","LU1868837136.USD","SOXQ","CGBL","LU2720916845.USD","SG9999003800.SGD","ABFL","BK4566","LU0109392836.USD","LU2065169927.USD","SNDG","LU2092937221.SGD","LU0345769631.USD","LU0444973449.USD","SCHA","LU0784383803.USD","BK4141","SG9999014906.USD","EMSF","IE00B7KXQ091.USD","LU0128525929.USD","LU0053666078.USD","LU1803068623.USD","HK0000306701.USD","LU1814569148.SGD","LU2471134952.CNY","SG9999014567.USD","LU0175139822.USD","LU0158827948.USD","LU2272731782.SGD","TMSL","BK4598","LU2023250843.SGD","NVDU","IE00BK4W5L77.USD","BK4555","HK0000914686.HKD","LU2326559502.SGD","TLA","LU0210528500.USD","LU0323591593.USD","SMOG","BK4548","LU2403377893.USD","LU0082616367.USD","PSI","LU2065171311.SGD","IE00BZ199S13.USD","LU1582986433.USD","TSII","LU1951198990.SGD","BK4534","IE0009G5SDU7.USD","IE000SO60NU8.SGD","MULL","LU0823411888.USD","FDTX","NVD3.UK","AAPE","OPTZ","IE00B19Z8X17.USD","LU1803068979.SGD","LU2089283258.USD","SG9999000418.SGD","LU1496350502.SGD","LU2242650005.HKD","FTEC","LU2023250504.SGD","LU2491049909.HKD","IE000BZT7R73.USD","SLS","LU1934455277.USD","LU2491050071.SGD","NVDO","CIBR","LU1699723380.USD","TTEQ","IE00B775SV38.USD","LU1145028129.USD","SGXZ80539844.SGD","LU0642271901.SGD","LU1066051811.HKD","LU2092937148.SGD","IE00B19Z3581.USD","LU0820561909.HKD","LU0276348264.USD","IE00BDRTCR15.USD","LU1988902786.USD","LU0795875086.SGD","BK4588","LU0203345920.USD","LU2430703251.USD","LU2063271972.USD","IE00BVYPNP33.GBP","LU1923623000.USD","LU2462591350.SGD","LU1548497426.USD","LU0011850046.USD","BK4608","CNEQ","COWG","IE0000B7K699.USD","SNDQ","CRSH","LU1732800096.USD","3NVD.UK","EGGY","LU0056508442.USD","LU0154236417.USD","LU2506952170.USD","LU1642822529.SGD","LU2471134523.USD","MIC","LU2087625088.SGD","IE00B7SZLL34.SGD","LU1670627923.USD","LU0963586101.USD","AVGO","LU1935042488.USD","LU2125909916.SGD","SG9999017495.SGD","AVGG","LU1280957306.USD","IE00BK4W5M84.HKD","XNTK","LU2506952097.USD","IE0034235188.USD","LU1721428933.USD","LU2100268510.USD","IE00BMPRXQ63.HKD","LU2087621335.USD","TRFK","LU0077335932.USD","LU0198837287.USD","FTXL","NVYY","LU2361044949.HKD","LU2125154778.USD","LU2756315664.SGD","SNVD.UK","TSLQ","LU1868836914.USD","MUG","LU0788109477.HKD","LU1861215975.USD","GTEK","LU2089284900.SGD","LU1861127337.USD","LU2463028550.USD","TSLS","LU1232071149.USD","IE0004091025.USD","LU2047632596.USD","HK0000304797.USD","IE000YTNTUN2.SGD","TEK","IE00BKVL7J92.USD","LU1400636491.USD","NVDY","LU2250418816.HKD","SG9999014880.SGD","BK4099","LU2750360641.GBP","LU1244550221.USD","LU1923622291.USD","SOXY","LU2954938101.SGD","LU2746668461.USD","LU2041044095.USD","BK4170","07788","LU2471134796.USD","NVDG","LU2148611432.USD","LU2168563687.JPY","LU2506951792.HKD","LU1979441026.SGD","NVII","LU2420271590.USD","LU2237957811.SGD","BK4516","LU0395794307.EUR","LU0820561818.USD","LU1868836591.USD","CGGO","SG9999002224.SGD","LU2764262908.HKD","IE00BZ9MQY76.HKD","LU1303367103.USD","LU0210536198.USD","NULC","LU0950375773.USD","LU1732799900.SGD","LU1069344957.HKD","09788","IE000KEQY171.SGD","IE00BWXC8680.SGD","IE00BDGV0183.EUR","IE0034235303.USD","LU0985320562.USD","LU2602419157.SGD","EFIV","LU0070302665.USD","CHPS","LU0138981039.USD","LU0251132253.USD","LU2211814178.USD","BK4573","LU0238689110.USD","LU1861558580.USD","SMH","LU2506951958.HKD","LU0070217475.USD","LU0170899867.USD","LU1169590202.USD","LU0417517546.SGD","AAPL","IE00B3PB1722.GBP","LU0314106906.USD","LU2592432038.USD","LU0708995401.HKD","LU1202635105.USD","ESUM","LU2083900584.USD","IE000WAW04H5.SGD","IE00BMPRXR70.SGD","MUZ","IE0005OL40V9.USD","BK4553","LU0308772762.SGD","ROM","SGXZ99366536.SGD","LU2279689827.SGD","BK4614","LU1066053197.SGD","LU0683600562.USD","LU0096364046.USD","LU1821325948.USD","LU0792757196.USD","LU2023250330.USD","LU0061475181.USD","LU1951200564.SGD","LU2237443465.HKD","HK0000320223.HKD","LU2237957902.USD","LU2361045086.USD","IE00B4YYXB79.USD","IE00BJLML261.HKD","SPTE","AVGU","LU1551013425.SGD","SG9999018857.SGD","TSLW","LU2290526834.HKD","TSLL","TSLY","QQQA","LU1127390331.HKD","LU1823568750.SGD","LU2896262040.SGD","IE00B894F039.SGD","IE00BJJMRY28.SGD","HK0000914660.USD","IE000ITXATA3.USD","HBMX","IE00BFSS7M15.SGD","LU2552382215.SGD","LU0314104364.USD","LU0107464264.USD","LU0889565833.HKD","LU2125909759.SGD","GB00BDT5M118.USD","LU2023251221.USD","LU2272731865.HKD","XLK","LU1839511570.USD","IE00BVYPNQ40.USD","LU1674673428.USD","LU1116320737.USD","LU1064131342.USD","IE00BZ1G4Q59.USD","SNDC","IE00BFSS8Q28.SGD","IE0004445239.USD","IETC","LU0784385170.HKD","LIT","LU0786609619.USD","LU1144417596.USD","LU2271345857.HKD","LU0345770993.USD","LU2381873111.SGD","IE00BD6J9T35.USD","ILDR","LU2430703178.SGD","IOSX","FXL","CHPX","LU1206712785.SGD","LU1046421795.USD","LU1935043023.USD","SG9999015978.USD","TESC","IE00BGHQDM52.EUR","LU1153585028.USD","LU2210149790.SGD","MRVL","AVL","LU1003077747.HKD","MRVX","LU1235294995.USD","NVDD","AVS","LU0345769128.USD","MUU","LU2462591277.SGD","BK4604","SG9999002232.USD","LU0823421333.USD","LU2237443382.USD","LU0965509101.SGD","LU0965508806.USD","09766","LU2168564149.EUR","LU0162691827.USD","LU2487616109.SGD","LU2264538146.SGD","SG9999004303.SGD","VT","NVDA","SNDU","LU1496350171.SGD","LU2552382132.HKD","LU0342679015.USD","WUGI","BK4576","LU0823414478.USD","BK4585","MUYY","APLY","LU0823417737.USD","BK4605","BAI","LU0225283273.USD","LU1934455194.USD","BK4529","AVGW","LU0320765646.SGD","LU0553294199.USD","LU1804176565.USD","QQQG","SAVGOmain","LU0784385840.USD","NVDW","BK4579","ARTY","LU0187121727.USD","AIS","LU0795875169.SGD","IE00BLSP4452.SGD","SG9999015945.SGD","LU1169589451.USD","LU1084165304.USD","LU2322448791.USD","DRMY","LU0354030511.USD","LU2473716301.USD","IE000Q6AESB8.SGD","LU2125154935.USD","BK4512","LU2095319765.USD","LU0724617625.USD","LU1815333072.USD","METV","LU1989772840.SGD","AAPU","LU0476273544.USD","LU1670628061.USD","IE00B42XCP33.USD","LU1261432733.SGD","TSLG","USXF","WISE","LU0106261372.USD","LU0868494708.USD","LU2106854487.HKD","LU0266013472.USD","LU0823414551.USD","IE000W1ABFV2.USD","IE00BN29S564.USD","LU2168564222.USD","LU0708994859.HKD","LU1400636657.SGD","LU1323610961.USD","AAPW","LU2237443549.SGD","BK4532","LU1645745479.HKD","THMR","LU0859254822.USD","SG9999015358.SGD","LU1992135399.USD","LU2347655073.USD","BK4505","LU0353189763.USD","AIPI","IE00B3S45H60.SGD","BK4139","IE00B19Z9Z06.USD","IE000MB6IJN5.SGD","FAI","LU1691799644.USD","LU2211815571.USD","LU0149725797.USD","LU1989764664.SGD","LU1852331112.SGD","LU0942090050.USD","IE00B19Z9505.USD","LU1162221912.USD","LU2213496289.HKD","LU2168564495.EUR","LU2237443978.SGD","LU2430703095.HKD","DISK","09388","BK4503","TDIV","AAPX","LU1670710588.SGD","LU1935042215.USD","IE00B5949003.HKD","WANT","IE00BKDWB100.SGD","LU1629891620.HKD","LU2244417387.USD","LU0267386448.USD","IE0009356076.USD","LU0889566641.SGD","SG9999014898.SGD","TSLI","BK4515","IE00BQXX3C00.GBP","LU1989772923.USD","LU2417539215.USD","IE00BMPRXN33.USD","LU0949170772.SGD","LU2065171402.SGD","IE00BBT3K403.USD","IE0001KFT4U8.USD","BK4571","LU1923622614.USD","AGOX","HK0000304805.HKD","BK4507","LU1670711040.USD","LU0211327993.USD","LU1934455863.HKD","BK4581","SAAPLmain","LU1267930573.SGD","AAPY","LU0661504455.SGD","LU1116320901.HKD","IE00BSNM7G36.USD","AIFD","IE00B1XK9C88.USD","BK4612","BK4575","LU0949170426.SGD","LU1244550577.SGD","LU1316542783.SGD","LU0174119429.USD","BK4592","NVDX","LU1935043536.SGD","LU1989764748.USD","MU","SMU00main","IE00BJTD4V19.USD","IE00BLSP4239.USD","LU2065170008.USD","SCHM","WATS","LU1670756490.USD","TSYY","TEST","07366","LU1035775433.USD","LU1582986359.USD","LU0061474705.USD","LU1720051017.SGD","LU2191332357.HKD","LU0057025933.USD","LU1242518931.SGD","LU0964807845.USD","LU1623119135.USD","RULE","LU0323239441.USD","IE00BDCRKT87.USD","LU0133085943.USD","LU1429558221.USD","LU0823421416.USD","LU2092627202.USD","LU0097036916.USD","LU0310800379.SGD","LU1242518857.USD","BK4554","SOXX","LU2413666426.HKD","LU0072462426.USD","LU2361044865.SGD","LU0234572021.USD","LU2360108059.USD","LU0545039389.USD","JGRO","BK4587","LU0347712357.USD","LU2236285917.USD","LU2458330243.SGD","LFGY","LU0234570918.USD","LU1791710400.SGD","TSLZ","IE00B775H168.HKD","IE00BVYPNW00.USD","NVDS","LU1880398554.USD","LU2931357623.SGD","TSLP","LU2054465674.USD","LU2272731600.USD","SGXZ51526630.SGD","LU1712237335.SGD","LU2764263039.SGD","AAPD","LU0096362180.USD","LU2357627491.SGD","LU0456855351.SGD","IE00BVYPNV92.GBP","LU2860962120.EUR","LU0528227936.USD","LU0787776722.HKD","LU0109391861.USD","LU2357305700.SGD","LU2543165471.USD","HK0000306685.HKD","BK4501","LU0912757837.SGD","LU1718418525.SGD","SG9999011175.SGD","CGDG","LU1267930730.SGD","LU0265550946.USD","LU0640476718.USD","LU0354030438.USD","LU0965509283.SGD","WLDR","07388","LU0203347892.USD","IE00B1BXHZ80.USD","LU0211328371.USD","SNDK","LU1267930490.SGD","LU0215105999.USD","LU0203201768.USD","LU2413666699.HKD","SG9999015952.SGD","LU0672654240.SGD","LU1868836757.USD","LU2048586759.USD","SGXZ81514606.USD","USD","LU0203202063.USD","LU0444971666.USD","LU2505996681.GBP","HAKY","LU2102340556.USD","LU0054578231.USD","LU1206713676.USD","LU2461242641.AUD","SMHX","PTF","LU2347655156.SGD","LU0390134368.USD","CHAT","IE00B4JS1V06.HKD","LU0079474960.USD","MVLL","BK4567","LU1582987324.SGD","LU2452424414.USD","LU2237438978.USD","LU0348723411.USD","LU0353189680.USD","LU2097344431.USD","LU0265550359.USD","LU2357125470.USD","LU2552382058.USD","SG9999015986.USD","LU0061474960.USD","MACW.SI","LU0256863811.USD","IE00B19Z8W00.USD","LU2111349929.HKD","BOBP","LU1861559042.SGD","LU1989771016.USD","LU0472753341.HKD","LU2237443895.HKD","LU1037948541.HKD","SGXZ31699556.SGD","SG9999014559.SGD","LU0069063385.USD","LU1435385759.SGD","LU1069347547.HKD","NVC","AIQ","IDRV","LU0689472784.USD","LU0320765489.SGD","LU2294711713.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047870","title":"Is SELLAS Life Sciences Group (SLS) Overvalued As Trial Milestones And Takeover Changes Stir Questions?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047870","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663047870?lang=en_us&edition=fundamental","pubTime":"2026-08-31 01:20","pubTimestamp":1788110406,"startTime":"0","endTime":"0","summary":"Trial Milestone and Executive Changes Put SELLAS Life Sciences Group Stock in Focus\nSELLAS Life Sciences Group (SLS) drew attention after a report indicated its phase 3 trial for acute myeloid leukemia reached the 80th patient death, a key trigger for Galinpepimut S results.\nThe company has not commented on this reported milestone. Recent amendments to executive employment agreements that add takeover related benefits have prompted investors to reassess what might be next for the stock.\nAt a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/is-sellas-life-sciences-group-sls-overvalued-as-trial-milest","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/is-sellas-life-sciences-group-sls-overvalued-as-trial-milest","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLS","BK7104","SLS.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663177050","title":"Is Uncertain Galinpepimut-S Data Timing Reshaping SELLAS Life Sciences Group’s (SLS) Strategic Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663177050","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663177050?lang=en_us&edition=fundamental","pubTime":"2026-08-29 23:21","pubTimestamp":1788016865,"startTime":"0","endTime":"0","summary":"Earlier this year, SELLAS Life Sciences Group came under scrutiny after reports that its phase 3 acute myeloid leukemia trial for Galinpepimut-S had reached a key mortality-related milestone without a corresponding company update.\nInvestor attention has also focused on recently amended executive employment agreements that include enhanced benefits in the event of a takeover, raising questions about potential corporate actions alongside the unresolved trial outcome.\nWe’ll now explore how the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/is-uncertain-galinpepimut-s-data-timing-reshaping-sellas-lif","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/is-uncertain-galinpepimut-s-data-timing-reshaping-sellas-lif","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","SLS.AU","BK4139","SLS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sellaslifesciences.com","stockEarnings":[{"period":"1week","weight":-0.145},{"period":"1month","weight":-0.1044},{"period":"3month","weight":0.0087},{"period":"6month","weight":1.1055},{"period":"1year","weight":4.19},{"period":"ytd","weight":1.7533}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.030636},{"month":2,"riseRate":0.5,"avgChangeRate":-0.01322},{"month":3,"riseRate":0.25,"avgChangeRate":-0.060862},{"month":4,"riseRate":0.5,"avgChangeRate":0.097703},{"month":5,"riseRate":0.75,"avgChangeRate":0.182109},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.13341},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.057089},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.025956},{"month":9,"riseRate":0.25,"avgChangeRate":-0.035609},{"month":10,"riseRate":0.333333,"avgChangeRate":0.033815},{"month":11,"riseRate":0.25,"avgChangeRate":-0.061889},{"month":12,"riseRate":0.25,"avgChangeRate":0.046982}],"exchange":"NASDAQ","name":"SELLAS Life Sciences Group Inc.","nameEN":"SELLAS Life Sciences Group Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SELLAS Life Sciences Group Inc.(SLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SELLAS Life Sciences Group Inc.(SLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SELLAS Life Sciences Group Inc.,SLS,SELLAS Life Sciences Group Inc.股票,SELLAS Life Sciences Group Inc.股票老虎,SELLAS Life Sciences Group Inc.股票老虎国际,SELLAS Life Sciences Group Inc.行情,SELLAS Life Sciences Group Inc.股票行情,SELLAS Life Sciences Group Inc.股价,SELLAS Life Sciences Group Inc.股市,SELLAS Life Sciences Group Inc.股票价格,SELLAS Life Sciences Group Inc.股票交易,SELLAS Life Sciences Group Inc.股票购买,SELLAS Life Sciences Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SELLAS Life Sciences Group Inc.(SLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SELLAS Life Sciences Group Inc.(SLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}